Menu

Velocity Clinical Research - Rockville, Maryland

Rockville, Maryland United States

Claim This Site

Are you the site administrator? Claim this site to update information.

55Total Trials
2Recruiting Trials
16Active Trials
33Completed Trials
54Unique Conditions
32Unique Sponsors

Conditions

COVID-19 (4)Respiratory Syncytial Virus (4)SARS-CoV-2 (4)Diabetes Mellitus (3)Gastroparesis (3)Hypercholesterolemia (3)Pneumococcal Disease (3)Chronic Obstructive Pulmonary Disease (2)

Sponsors

ModernaTX, Inc. (14)Merck Sharp & Dohme LLC (6)Janssen Vaccines & Prevention B.V. (4)Allergan (3)Pfizer (3)Apnimed (2)Biomedical Advanced Research and Development Authority (2)Phathom Pharmaceuticals, Inc. (2)

Affiliations

Associated Organizations

Basic Information

Site Overview

Velocity’s Internal Medicine research site in Rockville partners with Rockville Internal Medicine Group (RIMG) to conduct clinical trials for a broad range of investigational treatments, including vaccines and medicines developed to treat migraines, diabetes, acne, depression, high cholesterol, and other conditions. Founded in 1952, RIMG began conducting clinical trials with Meridian Clinical Research in 2018, before being acquired by Velocity in 2022. Located just off of I-270, the site is easily accessible to thousands of patients in the Potomac and Rockville areas, including those established with the practice and diverse populations. All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Rockville team is committed to being a resource for study participants, to providing the highest quality of patient care with compassion and kindness, and to advancing medicine through research.

Accessibility & Parking

Accessibility Features

Wheelchair accessible entrance
Wheelchair accessible parking lot
Wheelchair accessible restroom